Related Experiment Video

Updated: May 11, 2026

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy

Johanna K DiStefano1, Matthew Taila, M Lucrecia Alvarez

  • 1Diabetes, Cardiovascular and Metabolic Diseases Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA. jdistefano@tgen.org

Current Diabetes Reports
|May 14, 2013
PubMed

Insights

Epigenetic factors, especially microRNAs (miRNAs), play a key role in diabetic nephropathy development. This review highlights recent discoveries in miRNA mechanisms, genetic interactions, and their diagnostic and therapeutic potential for kidney disease.

Area of Science:

  • Nephrology
  • Genetics
  • Molecular Biology

Background:

  • Diabetic nephropathy causes are complex, with epigenetic factors like microRNAs (miRNAs) emerging as significant contributors.
  • Research on miRNAs in diabetic nephropathy is rapidly expanding, revealing new mechanisms and candidates.

Purpose of the Study:

  • To summarize recent findings on microRNAs in diabetic nephropathy.
  • To focus on novel miRNA candidates, mechanisms, and their interaction with genetic variations.
  • To review the diagnostic and therapeutic potential of miRNAs for diabetic nephropathy.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of emerging evidence on miRNA function in diabetic nephropathy.
  • Synthesis of findings on genetic variation and miRNA interplay.

Main Results:

  • Identification of new microRNA candidates involved in diabetic nephropathy.
  • Elucidation of novel mechanisms by which miRNAs regulate disease processes.
  • Exploration of the intersection between genetic variations and miRNA activity in disease modulation.

Conclusions:

  • MicroRNAs are crucial mediators in diabetic nephropathy.
  • Emerging research offers promising avenues for miRNA-based diagnostics and therapeutics.
  • Further investigation into genetic-miRNA interactions is warranted.

More Related Videos

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy07:45

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...